UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000017002 |
|---|---|
| Receipt number | R000019724 |
| Scientific Title | Phase 1 trial of Oxaliplatin/IRInotecan/S-1 (OX-IRIS) as first line chemotherapy for unresectable pancreatic cancer |
| Date of disclosure of the study information | 2015/04/01 |
| Last modified on | 2022/09/18 17:18:46 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/04/01 01:47:42 | ||
| 2 | Update | 2015/10/25 23:54:21 | UMIN ID1 |
|
| 3 | Update | 2015/10/25 23:58:50 | TEL Last name of contact person Last name of contact person TEL Name of person sending information Name of person sending information TEL |
|
| 4 | Update | 2015/11/06 21:28:39 | Public title Public title |
|
| 5 | Update | 2015/11/06 21:33:56 | Narrative objectives1 Primary outcomes Primary outcomes |
|
| 6 | Update | 2015/11/06 21:38:13 | Key inclusion criteria Key exclusion criteria |
|
| 7 | Update | 2015/11/06 21:41:01 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
| 8 | Update | 2016/04/01 09:55:57 | Name of primary person or sponsor Institute Department Organization |
|
| 9 | Update | 2018/04/03 09:11:02 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete |
|
| 10 | Update | 2019/10/04 11:08:52 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Division name Division name Zip code Address Name of person sending information Name of person sending information Division name Organization Organization Address Address Tel |
|
| 11 | Update | 2019/10/06 11:21:41 | UMIN ID2 |
|
| 12 | Update | 2019/10/06 13:23:28 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 13 | Update | 2019/10/06 13:25:07 | Recruitment status Date of IRB |
|
| 14 | Update | 2022/09/18 17:18:46 | Publication of results URL related to results and publications Date of the first journal publication of results |
